What does CUSIP 874060205 represent in this 13F holders report?

CUSIP 874060205 is the security identifier for TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS used to aggregate holder disclosures.

How many institutions held TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS in Q1 2026?

351 institutional investors reported TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS for Q1 2026. Use the holders table for investor-level position and value details.

TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK)

CUSIP: 874060205

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / SPONSORED ADS
Total 13F shares: 98,181,442
Share change: +14,498,142
Total reported value: $1,817,683,373
Put/Call ratio: 4.5%
Price per share: $18.52
Number of holders: 351
Value change: +$279,458,078
Number of buys: 222
Number of sells: 92

Quarterly Holders Quick Answers

What is CUSIP 874060205?
CUSIP 874060205 identifies TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2025

Recent filing periods for CUSIP 874060205:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital Research Global Investors	13F	Company	— class O/S missing	13,486,772	$210,258,775	—	31 Dec 2025	13F
MORGAN STANLEY	13F	Company	— class O/S missing	6,373,202	$99,358,235	—	31 Dec 2025	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	— class O/S missing	5,682,847	$88,595,585	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	— class O/S missing	4,805,235	$74,913,610	—	31 Dec 2025	13F
D. E. Shaw & Co., Inc.	13F	Company	— class O/S missing	4,293,750	$66,939,563	—	31 Dec 2025	13F
UBS Group AG	13F	Company	— class O/S missing	4,123,523	$64,285,724	—	31 Dec 2025	13F
FMR LLC	13F	Company	— class O/S missing	4,056,868	$63,246,574	—	31 Dec 2025	13F
BRANDES INVESTMENT PARTNERS, LP	13F	Company	— class O/S missing	3,881,882	$60,518,644	—	31 Dec 2025	13F
BlackRock, Inc.	13F	Company	— class O/S missing	2,731,598	$42,585,612	—	31 Dec 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	— class O/S missing	2,618,300	$40,819,297	—	31 Dec 2025	13F
FIRST TRUST ADVISORS LP	13F	Company	— class O/S missing	2,382,629	$37,145,183	—	31 Dec 2025	13F
VAN ECK ASSOCIATES CORP	13F	Company	— class O/S missing	2,305,397	$35,941,000	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	— class O/S missing	1,698,915	$26,486,086	—	31 Dec 2025	13F
MANAGED ASSET PORTFOLIOS, LLC	13F	Company	— class O/S missing	1,495,746	$23,318,677	—	31 Dec 2025	13F
Quantinno Capital Management LP	13F	Company	— class O/S missing	1,069,327	$16,670,821	—	31 Dec 2025	13F
WELLS FARGO & COMPANY/MN	13F	Company	— class O/S missing	1,060,461	$16,532,593	—	31 Dec 2025	13F
ENVESTNET ASSET MANAGEMENT INC	13F	Company	— class O/S missing	1,020,644	$15,911,840	—	31 Dec 2025	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	— class O/S missing	962,502	$15,005,406	—	31 Dec 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	— class O/S missing	890,089	$13,876,488	—	31 Dec 2025	13F
TORONTO DOMINION BANK	13F	Company	— class O/S missing	823,200	$12,833,688	—	31 Dec 2025	13F
Crossmark Global Holdings, Inc.	13F	Company	— class O/S missing	745,176	$11,617,293	—	31 Dec 2025	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	— class O/S missing	679,277	$10,589,928	—	31 Dec 2025	13F
Focus Partners Wealth	13F	Company	— class O/S missing	562,049	$8,760,659	—	31 Dec 2025	13F
STIFEL FINANCIAL CORP	13F	Company	— class O/S missing	554,290	$8,641,355	—	31 Dec 2025	13F
ROYAL BANK OF CANADA	13F	Company	— class O/S missing	554,126	$8,639,000	—	31 Dec 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	— class O/S missing	413,692	$6,449,458	—	31 Dec 2025	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	— class O/S missing	408,600	$6,370,074	—	31 Dec 2025	13F
Creative Planning	13F	Company	— class O/S missing	395,390	$6,164,125	—	31 Dec 2025	13F
CITADEL ADVISORS LLC	13F	Company	— class O/S missing	389,734	$6,075,953	—	31 Dec 2025	13F
FEDERATED HERMES, INC.	13F	Company	— class O/S missing	376,863	$5,875,294	—	31 Dec 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	— class O/S missing	362,868	$5,657,113	—	31 Dec 2025	13F
Bleakley Financial Group, LLC	13F	Company	— class O/S missing	362,758	$5,655,397	—	31 Dec 2025	13F
LPL Financial LLC	13F	Company	— class O/S missing	356,434	$5,556,805	—	31 Dec 2025	13F
Ethic Inc.	13F	Company	— class O/S missing	304,655	$4,749,575	—	31 Dec 2025	13F
TWO SIGMA ADVISERS, LP	13F	Company	— class O/S missing	298,400	$4,652,056	—	31 Dec 2025	13F
QRG CAPITAL MANAGEMENT, INC.	13F	Company	— class O/S missing	288,730	$4,501,303	—	31 Dec 2025	13F
Clean Yield Group	13F	Company	— class O/S missing	260,804	$4,065,934	—	31 Dec 2025	13F
HANTZ FINANCIAL SERVICES, INC.	13F	Company	— class O/S missing	253,478	$3,952,000	—	31 Dec 2025	13F
JPMORGAN CHASE & CO	13F	Company	— class O/S missing	242,179	$3,775,583	—	31 Dec 2025	13F
NATIXIS ADVISORS, LLC	13F	Company	— class O/S missing	227,754	$3,551,000	—	31 Dec 2025	13F
US BANCORP \DE\	13F	Company	— class O/S missing	217,528	$3,391,267	—	31 Dec 2025	13F
Pathstone Holdings, LLC	13F	Company	— class O/S missing	216,377	$3,373,312	—	31 Dec 2025	13F
MANNING & NAPIER ADVISORS LLC	13F	Company	— class O/S missing	215,727	$3,371,813	—	31 Dec 2025	13F
Cetera Investment Advisers	13F	Company	— class O/S missing	208,922	$3,257,105	—	31 Dec 2025	13F
Qube Research & Technologies Ltd	13F	Company	— class O/S missing	197,507	$3,079,134	—	31 Dec 2025	13F
Catalyst Capital Advisors LLC	13F	Company	— class O/S missing	192,000	$2,993,280	—	31 Dec 2025	13F
SEI INVESTMENTS CO	13F	Company	— class O/S missing	191,203	$2,980,986	—	31 Dec 2025	13F
Vestmark Advisory Solutions, Inc.	13F	Company	— class O/S missing	189,574	$2,955,462	—	31 Dec 2025	13F
Mariner, LLC	13F	Company	— class O/S missing	187,640	$2,925,749	—	31 Dec 2025	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	— class O/S missing	185,549	$2,892,709	—	31 Dec 2025	13F

Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2026

As of 31 Mar 2026, TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by 351 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 98,181,442 shares. The largest 10 holders included Capital Research Global Investors, FMR LLC, MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., GOLDMAN SACHS GROUP INC, BRANDES INVESTMENT PARTNERS, LP, BlackRock, Inc., ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, RENAISSANCE TECHNOLOGIES LLC, and UBS Group AG. This page lists 351 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

344

Q1 2026 holders

351

Holder diff

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.